Louisiana State Employees Retirement System Sells 200 Shares of Prestige Consumer Healthcare Inc. $PBH

Louisiana State Employees Retirement System cut its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 23,100 shares of the company’s stock after selling 200 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Prestige Consumer Healthcare were worth $1,845,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of PBH. GAMMA Investing LLC boosted its stake in Prestige Consumer Healthcare by 35.9% in the first quarter. GAMMA Investing LLC now owns 1,879 shares of the company’s stock valued at $162,000 after acquiring an additional 496 shares during the last quarter. NorthCrest Asset Manangement LLC bought a new position in Prestige Consumer Healthcare in the first quarter valued at approximately $651,000. Opal Wealth Advisors LLC bought a new position in Prestige Consumer Healthcare in the first quarter valued at approximately $38,000. QRG Capital Management Inc. boosted its stake in Prestige Consumer Healthcare by 8.6% in the first quarter. QRG Capital Management Inc. now owns 5,971 shares of the company’s stock valued at $513,000 after acquiring an additional 475 shares during the last quarter. Finally, Avior Wealth Management LLC boosted its stake in Prestige Consumer Healthcare by 38.2% in the first quarter. Avior Wealth Management LLC now owns 11,824 shares of the company’s stock valued at $1,017,000 after acquiring an additional 3,270 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Trading Down 3.0%

Shares of NYSE:PBH opened at $60.91 on Friday. Prestige Consumer Healthcare Inc. has a 12 month low of $60.77 and a 12 month high of $90.04. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The company’s fifty day simple moving average is $65.27 and its 200 day simple moving average is $76.14. The firm has a market cap of $3.00 billion, a price-to-earnings ratio of 14.30, a PEG ratio of 1.93 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The company had revenue of $249.53 million for the quarter, compared to analyst estimates of $260.71 million. During the same quarter in the previous year, the business earned $0.90 earnings per share. The company’s revenue was down 6.6% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on PBH shares. Wall Street Zen cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Sidoti raised shares of Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price target on the stock in a research report on Wednesday, September 24th. Zacks Research cut shares of Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research report on Thursday, September 4th. Weiss Ratings reissued a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research report on Wednesday. Finally, Canaccord Genuity Group reduced their price target on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Four analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $94.80.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.